List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 63 studies with search of:   "Clofarabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Conditions: Acute Lymphoblastic Leukemia;   Acute Myelogenous Leukemia
Interventions: Drug: Clofarabine;   Drug: Clofarabine
2 Recruiting Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Following an Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Acute Lymphocytic Leukemia;   Relapsed/Refractory Chronic Lymphocytic Leukemia;   Relapsed/Refractory Non Hodgkin's Lymphoma;   Hodgkins Disease;   Relapsed Refractory Multiple Myeloma
Interventions: Drug: Antithymocyte Globulin;   Drug: Clofarabine;   Drug: Clofarabine;   Drug: Clofarabine
3 Recruiting 2 Arm Study of Clofarabine IV in MDS Patients
Conditions: Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Clofarabine;   Drug: Clofarabine
4 Recruiting A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: clofarabine;   Drug: clofarabine
5 Recruiting Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Idarubicin;   Drug: Ara-C
6 Recruiting Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)
Condition: Myelodysplastic Syndromes
Interventions: Drug: Clofarabine;   Drug: Clofarabine
7 Completed Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With AML and High-Risk MDS.
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Clofarabine;   Drug: Clofarabine plus Ara-C
8 Recruiting Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Clofarabine;   Drug: Cytarabine;   Drug: Decitabine
9 Recruiting Oral Clofarabine for Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: Clofarabine
10 Suspended Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
Conditions: Myelodysplastic Syndromes;   Acute Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Cytarabine;   Drug: Thymoglobulin;   Procedure: Stem cell infusion
11 Recruiting Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: clofarabine;   Drug: Ara-C
12 Recruiting Low-Dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Conditions: Cancer;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Clofarabine
13 Recruiting Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Clofarabine
14 Recruiting A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: clofarabine;   Drug: clofarabine
15 Active, not recruiting A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
Conditions: Acute Myelogenous Leukemia;   Acute Myeloid Leukemia
Intervention: Drug: clofarabine (IV formulation)
16 Recruiting Clofarabine Bone Marrow Cytoreduction
Condition: Leukemia
Intervention: Drug: Clofarabine
17 Recruiting Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia;   Chronic Lymphocytic Leukemia
Intervention: Drug: Oral Clofarabine
18 Recruiting Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Condition: B-Cell Lymphoma
Intervention: Drug: Clofarabine
19 Recruiting A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Conditions: Acute Lymphoblastic Leukemia;   Acute Myelogenous Leukemia;   Relapsed Leukemia
Intervention: Drug: clofarabine (IV formulation), etoposide, cyclophosphamide
20 Recruiting A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Condition: Acute Myelogenous Leukemia
Interventions: Drug: clofarabine (IV formulation) and cytarabine;   Drug: placebo and cytarabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services